GSK-3β Inhibitors Therapeutics Market Report: Drug Discovery Trends
"According to the latest report published by Data Bridge Market Research, the Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors Therapeutics Market The global glycogen synthase kinase 3 beta (GSK-3β) inhibitors therapeutics market size was valued at USD 2.19 billion in 2024 and is projected to reach USD 3.29 billion by 2032, with a CAGR of 5.20% during the forecast period...
0 Комментарии 0 Поделились 11 Просмотры 0 предпросмотр